HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

YZYBIO-B

3.300

0.000

Volume:- -

Turnover:- -

Market Cap:640.20M

PE:-6.46

High:3.300

Open:3.300

Low:3.300

Close:3.300

52wk High:8.400

52wk Low:3.300

Shares:194.00M

HK Float Shares:179.48M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.511

ROE:-704.81%

ROA:-6.51%

PB:-9.35

PE(LYR):-6.46

PS:8.72

Loading ...

Overview Company News Filings

YZYBIO-B Plans RMB83 Million Connected Share Placement; Founders Seek Whitewash Waiver to Lift Concerted Stake Above 50%

Bulletin Express

Wuhan YZY Biopharma Co - to Issue 35.6 Mln Domestic Shares at Rmb2.43 Per Share

THOMSON REUTERS

YZYBIO-B Maintains Stable Share Base in August; 0.50 Million Options Lapse Under 2024 Plan

Bulletin Express

YZYBIO-B Trading Halt Announced Pending Insider Information Disclosure

Trading in Wuhan YZY Biopharma H Shares Halted at 9:00 A.m. on Aug 31, 2026

THOMSON REUTERS

YZYBIO-B Reports Narrowed Interim Loss of RMB 6.26 Million, Down 89.36% Year-on-Year

YZYBIO-B Narrows H1 Loss on Lower R&D Spend; M701 NDA Accepted, Pipeline Advances

Bulletin Express

Wuhan YZY Biopharma H1 FY26 Net Loss Narrows to RMB 6.26 Million; Revenue Falls 10.87% to RMB 33.14 Million

YZYBIO-B schedules 28 Aug 2026 board session to approve 1H 2026 interim results

Bulletin Express

Wuhan YZY Biopharma Schedules Board Meeting to Review Interim Results

YZY Biopharma Reports No Change in Share Capital for July 2026; 1.25 Million Options Outstanding

Bulletin Express

YZYBIO-B (02496) to Present Clinical Data for M701 at 2026 ASCO Annual Meeting

Wuhan YZY Biopharma says Phase III M701 trial prolongs puncture-free survival in malignant ascites

YZYBIO-B Announces Supervisor Transition: Dr. Shi Jian Steps Down, Ms. Fang Lijuan Elected as Employee Representative

Bulletin Express

YZYBIO-B (02496) Announces Election of Fang Lijuan as Second-Term Employee Representative Supervisor

Wuhan Yzy Biopharma names Fang Lijuan employee representative supervisor, replacing Shi Jian

Wuhan YZY Biopharma’s NDA for Bispecific Antibody M701 Wins NMPA Acceptance

Bulletin Express

YZYBIO-B Receives NMPA Acceptance for M701 New Drug Application Targeting Malignant Ascites

BRIEF-Wuhan Yzy Biopharma Co Says NDA For M701 Accepted By NMPA For Treatment Of Malignant Ascites

Wuhan YZY Biopharma says China regulator accepts M701 NDA for malignant ascites

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/02496/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"02496","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02496\",,,,,undefined,":{"symbol":"02496","market":"HK","secType":"STK","nameCN":"YZYBIO-B","latestPrice":3.3,"timestamp":1789002001116,"preClose":3.3,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":179479113,"shares":194000000,"eps":-0.5111211553957625,"marketStatus":"Closed","change":0,"latestTime":"09-10 09:00:01","open":3.3,"high":3.3,"low":3.3,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":3.205,"bidSize":200,"shortable":0,"etf":0,"ttmEps":-0.1939838223734768,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789090200000},"marketStatusCode":5,"adr":0,"listingDate":1695571200000,"exchange":"SEHK","adjPreClose":3.3,"openAndCloseTimeList":[[1789003800000,1789012800000],[1789016400000,1789027200000]],"volumeRatio":0,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02496\",,,,,undefined,":{"symbol":"02496","floatShares":179479113,"roa":"-6.51%","roe":"-704.81%","lyrEps":-0.511121,"shares":194000000,"dividePrice":0,"high":3.3,"amplitude":0,"preClose":3.3,"low":3.3,"week52Low":3.3,"pbRate":"-9.35","psRate":"8.72","week52High":8.4,"institutionHeld":0,"latestPrice":3.3,"committee":1,"eps":-0.5111211553957625,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.1939838223734768,"open":3.3,"prevYearClose":8.02,"prevWeekClose":3.3,"prevMonthClose":3.3,"prevQuarterClose":3.8,"fiveDayClose":3.3,"twentyDayClose":3.6,"sixtyDayClose":4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02496\",params:#limit:5,,,undefined,":[{"date":"2026-08-28","symbol":"02496","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787880600000,"name":null,"time":"","dateTimestamp":1787846400000,"actualEps":null},{"date":"2026-03-27","symbol":"02496","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774575000000,"name":null,"time":"","dateTimestamp":1774540800000,"actualEps":null},{"date":"2025-08-26","symbol":"02496","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null},{"date":"2025-03-28","symbol":"02496","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743125400000,"name":null,"time":"Post-Mkt","dateTimestamp":1743091200000,"actualEps":null},{"date":"2024-08-29","symbol":"02496","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724895000000,"name":null,"time":"","dateTimestamp":1724860800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02496\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02496\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02496\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02496","date":"2026-09-09","current":-17.011728,"percent":0.048077,"low":-18.565593,"twenty":-12.714572,"median":-8.249766,"eighty":-6.971794,"high":-3.741546,"avg":-9.446342,"sd":3.6633,"marketCap":639702360},"quantilePoints":[{"date":"2023-09-22","current":-15.261024,"twenty":-15.274233,"median":-15.26928,"eighty":-15.264326,"marketCap":3088019200},{"date":"2023-09-29","current":-15.292224,"twenty":-17.099581,"median":-15.293234,"eighty":-15.280473,"marketCap":3049418960},{"date":"2023-10-06","current":-15.493216,"twenty":-15.501023,"median":-15.292224,"eighty":-15.050323,"marketCap":3088019200},{"date":"2023-10-13","current":-15.380625,"twenty":-15.493216,"median":-15.348538,"eighty":-15.261024,"marketCap":3060999032},{"date":"2023-10-20","current":-10.535817,"twenty":-15.418704,"median":-15.300038,"eighty":-14.801616,"marketCap":2093571360},{"date":"2023-10-27","current":-9.759574,"twenty":-15.417248,"median":-15.292224,"eighty":-11.937608,"marketCap":1938492000},{"date":"2023-11-03","current":-9.733728,"twenty":-15.412338,"median":-15.155674,"eighty":-10.478048,"marketCap":1938492000},{"date":"2023-11-10","current":-8.275398,"twenty":-15.390041,"median":-14.508961,"eighty":-9.494912,"marketCap":1647718200},{"date":"2023-11-17","current":-8.703164,"twenty":-15.38145,"median":-11.695259,"eighty":-8.750672,"marketCap":1748519784},{"date":"2023-11-24","current":-8.421561,"twenty":-15.329285,"median":-10.573898,"eighty":-8.701771,"marketCap":1705872960},{"date":"2023-12-01","current":-7.919793,"twenty":-15.30332,"median":-10.003273,"eighty":-8.541365,"marketCap":1610886852},{"date":"2023-12-08","current":-8.497372,"twenty":-15.294595,"median":-9.516549,"eighty":-8.420238,"marketCap":1721380896},{"date":"2023-12-15","current":-8.258301,"twenty":-15.292426,"median":-9.276148,"eighty":-8.274722,"marketCap":1682611056},{"date":"2023-12-22","current":-8.349506,"twenty":-15.280473,"median":-8.776546,"eighty":-8.277258,"marketCap":1700057484},{"date":"2023-12-29","current":-8.428335,"twenty":-15.270931,"median":-8.740745,"eighty":-8.306436,"marketCap":1725257880},{"date":"2024-01-05","current":-8.249766,"twenty":-15.218884,"median":-8.699682,"eighty":-8.272694,"marketCap":1676795580},{"date":"2024-01-12","current":-8.302569,"twenty":-15.000582,"median":-8.571321,"eighty":-8.275563,"marketCap":1688426532},{"date":"2024-01-19","current":-8.113537,"twenty":-14.743085,"median":-8.513713,"eighty":-8.272694,"marketCap":1647718200},{"date":"2024-01-26","current":-7.982332,"twenty":-14.471602,"median":-8.481448,"eighty":-8.258393,"marketCap":1614763836},{"date":"2024-02-02","current":-7.992522,"twenty":-13.915342,"median":-8.424948,"eighty":-8.196137,"marketCap":1614763836},{"date":"2024-02-09","current":-8.02019,"twenty":-12.050937,"median":-8.406699,"eighty":-8.080173,"marketCap":1628333280},{"date":"2024-02-16","current":-8.343013,"twenty":-11.339581,"median":-8.370574,"eighty":-8.105196,"marketCap":1694242008},{"date":"2024-02-23","current":-8.30086,"twenty":-10.803844,"median":-8.369483,"eighty":-8.124586,"marketCap":1676795580},{"date":"2024-03-01","current":-8.247733,"twenty":-10.604956,"median":-8.362825,"eighty":-8.153154,"marketCap":1667103120},{"date":"2024-03-08","current":-8.186551,"twenty":-10.543433,"median":-8.343013,"eighty":-8.173812,"marketCap":1655472168},{"date":"2024-03-15","current":-8.155425,"twenty":-10.30474,"median":-8.311389,"eighty":-8.173276,"marketCap":1647718200},{"date":"2024-03-22","current":-7.39462,"twenty":-9.857053,"median":-8.302569,"eighty":-8.105196,"marketCap":1492638840},{"date":"2024-03-28","current":-7.61103,"twenty":-9.744066,"median":-8.301568,"eighty":-8.043049,"marketCap":1531408680},{"date":"2024-04-05","current":-7.288366,"twenty":-9.690292,"median":-8.300787,"eighty":-8.021295,"marketCap":1512023760},{"date":"2024-04-12","current":-6.976051,"twenty":-9.494912,"median":-8.295352,"eighty":-7.983468,"marketCap":1448053524},{"date":"2024-04-19","current":-6.963318,"twenty":-9.388856,"median":-8.276973,"eighty":-7.977458,"marketCap":1444176540},{"date":"2024-04-26","current":-6.971914,"twenty":-9.296949,"median":-8.272018,"eighty":-7.930221,"marketCap":1444176540},{"date":"2024-05-03","current":-6.976736,"twenty":-9.241479,"median":-8.264756,"eighty":-7.6347,"marketCap":1444176540},{"date":"2024-05-10","current":-6.960212,"twenty":-8.933122,"median":-8.256463,"eighty":-7.598809,"marketCap":1444176540},{"date":"2024-05-17","current":-6.970443,"twenty":-8.807861,"median":-8.251559,"eighty":-7.39462,"marketCap":1444176540},{"date":"2024-05-24","current":-7.095514,"twenty":-8.76114,"median":-8.247733,"eighty":-7.267873,"marketCap":1444176540},{"date":"2024-05-31","current":-7.0883,"twenty":-8.730819,"median":-8.237322,"eighty":-7.171233,"marketCap":1444176540},{"date":"2024-06-07","current":-7.097101,"twenty":-8.707372,"median":-8.195562,"eighty":-7.097101,"marketCap":1444176540},{"date":"2024-06-14","current":-7.132215,"twenty":-8.698985,"median":-8.193432,"eighty":-7.097238,"marketCap":1449992016},{"date":"2024-06-21","current":-7.988022,"twenty":-8.625304,"median":-8.18531,"eighty":-7.098087,"marketCap":1620579312},{"date":"2024-06-28","current":-7.48471,"twenty":-8.574009,"median":-8.177364,"eighty":-7.098775,"marketCap":1517839236},{"date":"2024-07-05","current":-7.715801,"twenty":-8.562528,"median":-8.159606,"eighty":-7.101937,"marketCap":1564363044},{"date":"2024-07-12","current":-7.141207,"twenty":-8.536784,"median":-8.120442,"eighty":-7.107036,"marketCap":1449992016},{"date":"2024-07-19","current":-7.131527,"twenty":-8.514561,"median":-8.053748,"eighty":-7.107036,"marketCap":1448053524},{"date":"2024-07-26","current":-7.10513,"twenty":-8.504633,"median":-8.029564,"eighty":-7.105677,"marketCap":1448053524},{"date":"2024-08-02","current":-7.109273,"twenty":-8.491002,"median":-8.019114,"eighty":-7.105677,"marketCap":1448053524},{"date":"2024-08-09","current":-7.033842,"twenty":-8.475712,"median":-7.991974,"eighty":-7.097834,"marketCap":1442238048},{"date":"2024-08-16","current":-6.879903,"twenty":-8.451599,"median":-7.985142,"eighty":-7.095806,"marketCap":1411222176},{"date":"2024-08-23","current":-6.041633,"twenty":-8.425625,"median":-7.981406,"eighty":-7.090359,"marketCap":1244511864},{"date":"2024-08-30","current":-6.047183,"twenty":-8.418914,"median":-7.97694,"eighty":-7.085583,"marketCap":1219311468},{"date":"2024-09-06","current":-6.034663,"twenty":-8.411646,"median":-7.942728,"eighty":-7.024202,"marketCap":1217372976},{"date":"2024-09-13","current":-6.050501,"twenty":-8.400619,"median":-7.919793,"eighty":-6.989131,"marketCap":1217372976},{"date":"2024-09-20","current":-5.899508,"twenty":-8.390451,"median":-7.809695,"eighty":-6.977241,"marketCap":1194111072},{"date":"2024-09-27","current":-5.635763,"twenty":-8.383344,"median":-7.722148,"eighty":-6.974189,"marketCap":1147587264},{"date":"2024-10-04","current":-6.646499,"twenty":-8.371665,"median":-7.71452,"eighty":-6.971914,"marketCap":1347251940},{"date":"2024-10-10","current":-6.670566,"twenty":-8.369919,"median":-7.665604,"eighty":-6.970443,"marketCap":1343374956},{"date":"2024-10-18","current":-5.989499,"twenty":-8.366581,"median":-7.61103,"eighty":-6.964903,"marketCap":1199926548},{"date":"2024-10-25","current":-5.941495,"twenty":-8.363757,"median":-7.592567,"eighty":-6.963278,"marketCap":1190234088},{"date":"2024-11-01","current":-5.753759,"twenty":-8.362581,"median":-7.48471,"eighty":-6.932913,"marketCap":1153402740},{"date":"2024-11-08","current":-5.323409,"twenty":-8.352088,"median":-7.478194,"eighty":-6.706839,"marketCap":1062293616},{"date":"2024-11-15","current":-4.810927,"twenty":-8.344312,"median":-7.39462,"eighty":-6.66868,"marketCap":949861080},{"date":"2024-11-22","current":-4.597104,"twenty":-8.320901,"median":-7.288282,"eighty":-6.614502,"marketCap":907214256},{"date":"2024-11-29","current":-4.511723,"twenty":-8.314189,"median":-7.193914,"eighty":-6.4628,"marketCap":889767828},{"date":"2024-12-06","current":-3.832688,"twenty":-8.309887,"median":-7.189483,"eighty":-6.054759,"marketCap":754073388},{"date":"2024-12-13","current":-3.741546,"twenty":-8.30727,"median":-7.147179,"eighty":-6.049837,"marketCap":734688468},{"date":"2024-12-20","current":-3.946605,"twenty":-8.303428,"median":-7.141207,"eighty":-6.034627,"marketCap":771519816},{"date":"2024-12-27","current":-6.936731,"twenty":-8.302316,"median":-7.140369,"eighty":-6.034555,"marketCap":1355005908},{"date":"2025-01-03","current":-7.8123,"twenty":-8.301863,"median":-7.141207,"eighty":-6.034663,"marketCap":1527531696},{"date":"2025-01-10","current":-7.782302,"twenty":-8.301426,"median":-7.145546,"eighty":-6.036057,"marketCap":1515900744},{"date":"2025-01-17","current":-7.348445,"twenty":-8.300831,"median":-7.189317,"eighty":-6.042743,"marketCap":1432545588},{"date":"2025-01-24","current":-7.302687,"twenty":-8.300293,"median":-7.192391,"eighty":-6.047847,"marketCap":1432545588},{"date":"2025-01-28","current":-7.264616,"twenty":-8.299451,"median":-7.229265,"eighty":-6.049174,"marketCap":1432545588},{"date":"2025-02-07","current":-7.236748,"twenty":-8.296655,"median":-7.256521,"eighty":-6.050501,"marketCap":1418976144},{"date":"2025-02-14","current":-6.936954,"twenty":-8.289567,"median":-7.234585,"eighty":-6.050566,"marketCap":1356944400},{"date":"2025-02-21","current":-6.209204,"twenty":-8.280918,"median":-7.193914,"eighty":-6.051176,"marketCap":1221249960},{"date":"2025-02-28","current":-5.735312,"twenty":-8.276823,"median":-7.189483,"eighty":-6.049174,"marketCap":1124325360},{"date":"2025-03-07","current":-4.382772,"twenty":-8.275728,"median":-7.147179,"eighty":-6.034591,"marketCap":862628940},{"date":"2025-03-14","current":-4.381178,"twenty":-8.27337,"median":-7.141207,"eighty":-6.005336,"marketCap":862628940},{"date":"2025-03-21","current":-4.382899,"twenty":-8.271865,"median":-7.139645,"eighty":-5.976203,"marketCap":862628940},{"date":"2025-03-28","current":-6.03007,"twenty":-8.267559,"median":-7.132215,"eighty":-5.958282,"marketCap":1184418612},{"date":"2025-04-03","current":-12.27285,"twenty":-8.275893,"median":-7.137062,"eighty":-5.959979,"marketCap":1279404720},{"date":"2025-04-11","current":-11.044555,"twenty":-8.297306,"median":-7.141207,"eighty":-5.971601,"marketCap":1143710280},{"date":"2025-04-17","current":-8.683774,"twenty":-8.301426,"median":-7.143912,"eighty":-5.986226,"marketCap":901398780},{"date":"2025-04-25","current":-8.769575,"twenty":-8.306866,"median":-7.147536,"eighty":-5.989499,"marketCap":911091240},{"date":"2025-05-02","current":-8.750975,"twenty":-8.320901,"median":-7.189649,"eighty":-5.997241,"marketCap":911091240},{"date":"2025-05-09","current":-8.320184,"twenty":-8.320865,"median":-7.193914,"eighty":-5.999307,"marketCap":872321400},{"date":"2025-05-16","current":-7.720916,"twenty":-8.320762,"median":-7.234585,"eighty":-6.005336,"marketCap":816105132},{"date":"2025-05-23","current":-7.734459,"twenty":-8.320415,"median":-7.256521,"eighty":-6.010152,"marketCap":819982116},{"date":"2025-05-30","current":-7.700604,"twenty":-8.317297,"median":-7.263991,"eighty":-6.01222,"marketCap":819982116},{"date":"2025-06-06","current":-7.681007,"twenty":-8.314485,"median":-7.286363,"eighty":-6.02333,"marketCap":819982116},{"date":"2025-06-13","current":-9.456792,"twenty":-8.320762,"median":-7.288884,"eighty":-6.03007,"marketCap":1009954332},{"date":"2025-06-20","current":-9.38443,"twenty":-8.354671,"median":-7.302687,"eighty":-6.032718,"marketCap":1000261872},{"date":"2025-06-27","current":-8.886685,"twenty":-8.370356,"median":-7.33658,"eighty":-6.034591,"marketCap":949861080},{"date":"2025-07-04","current":-8.886268,"twenty":-8.400619,"median":-7.39462,"eighty":-6.034663,"marketCap":949861080},{"date":"2025-07-11","current":-9.439834,"twenty":-8.450162,"median":-7.477671,"eighty":-6.037451,"marketCap":1008015840},{"date":"2025-07-18","current":-10.71898,"twenty":-8.504633,"median":-7.483524,"eighty":-6.043853,"marketCap":1143710280},{"date":"2025-07-25","current":-10.354306,"twenty":-8.575353,"median":-7.586326,"eighty":-6.04851,"marketCap":1108817424},{"date":"2025-08-01","current":-10.200109,"twenty":-8.700378,"median":-7.607601,"eighty":-6.050501,"marketCap":1085555520},{"date":"2025-08-08","current":-10.174658,"twenty":-8.73051,"median":-7.6347,"eighty":-6.050545,"marketCap":1085555520},{"date":"2025-08-15","current":-10.189926,"twenty":-8.755577,"median":-7.668855,"eighty":-6.050988,"marketCap":1085555520},{"date":"2025-08-22","current":-10.404516,"twenty":-8.778653,"median":-7.696508,"eighty":-6.053156,"marketCap":1104940440},{"date":"2025-08-29","current":-12.496435,"twenty":-8.886268,"median":-7.699076,"eighty":-6.05556,"marketCap":1066170600},{"date":"2025-09-05","current":-12.508831,"twenty":-8.917527,"median":-7.704882,"eighty":-6.055623,"marketCap":1066170600},{"date":"2025-09-12","current":-12.713379,"twenty":-9.283082,"median":-7.709288,"eighty":-6.056629,"marketCap":1085555520},{"date":"2025-09-19","current":-13.812899,"twenty":-9.372197,"median":-7.711903,"eighty":-6.091088,"marketCap":1178603136},{"date":"2025-09-26","current":-15.488824,"twenty":-9.421871,"median":-7.713577,"eighty":-6.168118,"marketCap":1318174560},{"date":"2025-10-03","current":-15.429223,"twenty":-9.439834,"median":-7.716349,"eighty":-6.209251,"marketCap":1316236068},{"date":"2025-10-10","current":-15.542765,"twenty":-9.48241,"median":-7.718907,"eighty":-6.209438,"marketCap":1323990036},{"date":"2025-10-17","current":-15.463777,"twenty":-9.516549,"median":-7.722508,"eighty":-6.564001,"marketCap":1316236068},{"date":"2025-10-24","current":-16.141138,"twenty":-9.993637,"median":-7.727404,"eighty":-6.587794,"marketCap":1374390828},{"date":"2025-10-31","current":-15.935241,"twenty":-10.174658,"median":-7.732892,"eighty":-6.604283,"marketCap":1358882892},{"date":"2025-11-07","current":-15.945201,"twenty":-10.180758,"median":-7.758053,"eighty":-6.609789,"marketCap":1358882892},{"date":"2025-11-14","current":-15.900146,"twenty":-10.200109,"median":-7.784219,"eighty":-6.614502,"marketCap":1358882892},{"date":"2025-11-21","current":-16.089098,"twenty":-10.29964,"median":-7.809695,"eighty":-6.640318,"marketCap":1374390828},{"date":"2025-11-28","current":-16.030869,"twenty":-10.386607,"median":-7.849274,"eighty":-6.646499,"marketCap":1374390828},{"date":"2025-12-05","current":-16.003355,"twenty":-10.404516,"median":-7.919793,"eighty":-6.658209,"marketCap":1374390828},{"date":"2025-12-12","current":-15.973808,"twenty":-10.577045,"median":-7.942728,"eighty":-6.66868,"marketCap":1374390828},{"date":"2025-12-19","current":-15.93625,"twenty":-10.714182,"median":-7.97694,"eighty":-6.670691,"marketCap":1374390828},{"date":"2025-12-24","current":-15.662693,"twenty":-10.90375,"median":-7.980005,"eighty":-6.674625,"marketCap":1355005908},{"date":"2026-01-02","current":-17.543083,"twenty":-11.095447,"median":-7.982691,"eighty":-6.684863,"marketCap":1523654712},{"date":"2026-01-09","current":-17.49951,"twenty":-11.336885,"median":-7.988022,"eighty":-6.703505,"marketCap":1523654712},{"date":"2026-01-16","current":-17.442827,"twenty":-12.451475,"median":-7.994219,"eighty":-6.740071,"marketCap":1523654712},{"date":"2026-01-23","current":-17.215232,"twenty":-12.506134,"median":-8.02019,"eighty":-6.870823,"marketCap":1502331300},{"date":"2026-01-30","current":-17.402236,"twenty":-12.672793,"median":-8.041443,"eighty":-6.879903,"marketCap":1525593204},{"date":"2026-02-06","current":-16.762691,"twenty":-13.116393,"median":-8.071832,"eighty":-6.881774,"marketCap":1473253920},{"date":"2026-02-13","current":-15.877471,"twenty":-13.767462,"median":-8.141386,"eighty":-6.889262,"marketCap":1403468208},{"date":"2026-02-20","current":-15.900374,"twenty":-14.02108,"median":-8.157515,"eighty":-6.889266,"marketCap":1403468208},{"date":"2026-02-27","current":-15.727885,"twenty":-14.413548,"median":-8.177364,"eighty":-6.902973,"marketCap":1403468208},{"date":"2026-03-06","current":-12.483086,"twenty":-14.626023,"median":-8.18531,"eighty":-6.913266,"marketCap":1104940440},{"date":"2026-03-13","current":-12.425855,"twenty":-14.413548,"median":-8.193432,"eighty":-6.925983,"marketCap":1104940440},{"date":"2026-03-20","current":-12.823206,"twenty":-14.349192,"median":-8.196999,"eighty":-6.935617,"marketCap":1135956312},{"date":"2026-03-27","current":-9.060567,"twenty":-14.332776,"median":-8.234591,"eighty":-6.936865,"marketCap":800597196},{"date":"2026-04-02","current":-8.304746,"twenty":-14.318035,"median":-8.244293,"eighty":-6.936954,"marketCap":800597196},{"date":"2026-04-10","current":-9.618041,"twenty":-14.311841,"median":-8.248749,"eighty":-6.936954,"marketCap":934353144},{"date":"2026-04-17","current":-9.614004,"twenty":-13.827239,"median":-8.252895,"eighty":-6.946166,"marketCap":934353144},{"date":"2026-04-24","current":-9.573569,"twenty":-13.812899,"median":-8.25853,"eighty":-6.950948,"marketCap":930476160},{"date":"2026-04-30","current":-9.168948,"twenty":-13.631151,"median":-8.268259,"eighty":-6.958359,"marketCap":891706320},{"date":"2026-05-08","current":-8.743175,"twenty":-13.502409,"median":-8.275398,"eighty":-6.962537,"marketCap":852936480},{"date":"2026-05-15","current":-10.226462,"twenty":-13.419752,"median":-8.281283,"eighty":-6.963278,"marketCap":1000261872},{"date":"2026-05-22","current":-10.249888,"twenty":-13.229802,"median":-8.295352,"eighty":-6.963681,"marketCap":1000261872},{"date":"2026-05-29","current":-8.511974,"twenty":-13.133287,"median":-8.300714,"eighty":-6.963936,"marketCap":833551560},{"date":"2026-06-05","current":-8.301973,"twenty":-12.941558,"median":-8.301752,"eighty":-6.964084,"marketCap":814166640},{"date":"2026-06-12","current":-8.307592,"twenty":-12.828822,"median":-8.301973,"eighty":-6.964705,"marketCap":814166640},{"date":"2026-06-18","current":-7.893055,"twenty":-12.823206,"median":-8.301937,"eighty":-6.9664,"marketCap":775396800},{"date":"2026-06-26","current":-7.5352,"twenty":-12.80087,"median":-8.300843,"eighty":-6.968747,"marketCap":736626960},{"date":"2026-07-03","current":-7.529568,"twenty":-12.757166,"median":-8.299661,"eighty":-6.969565,"marketCap":736626960},{"date":"2026-07-10","current":-7.53882,"twenty":-12.715765,"median":-8.28571,"eighty":-6.970443,"marketCap":736626960},{"date":"2026-07-17","current":-7.512086,"twenty":-12.713379,"median":-8.276973,"eighty":-6.970666,"marketCap":736626960},{"date":"2026-07-24","current":-7.292992,"twenty":-12.672793,"median":-8.272018,"eighty":-6.97157,"marketCap":715303548},{"date":"2026-07-31","current":-7.279164,"twenty":-12.510448,"median":-8.264756,"eighty":-6.971614,"marketCap":715303548},{"date":"2026-08-07","current":-7.186303,"twenty":-12.508831,"median":-8.256463,"eighty":-6.971914,"marketCap":707549580},{"date":"2026-08-14","current":-7.078899,"twenty":-12.508831,"median":-8.250223,"eighty":-6.973489,"marketCap":697857120},{"date":"2026-08-21","current":-7.06329,"twenty":-12.507767,"median":-8.246013,"eighty":-6.973742,"marketCap":697857120},{"date":"2026-08-28","current":-6.473214,"twenty":-12.50543,"median":-8.234591,"eighty":-6.971559,"marketCap":639702360},{"date":"2026-09-04","current":-17.049204,"twenty":-12.510448,"median":-8.246013,"eighty":-6.971614,"marketCap":639702360},{"date":"2026-09-09","current":-17.02196,"twenty":-12.714572,"median":-8.249766,"eighty":-6.971794,"marketCap":639702360}],"updateTime":1789032873407},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02496\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1187115038","title":"YZYBIO-B Plans RMB83 Million Connected Share Placement; Founders Seek Whitewash Waiver to Lift Concerted Stake Above 50%","url":"https://stock-news.laohu8.com/highlight/detail?id=1187115038","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187115038?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:41","pubTimestamp":1788961300,"startTime":"0","endTime":"0","summary":"Wuhan YZY Biopharma Co., Ltd. (YZYBIO-B) announced a conditional share placement to three founder-directors—Dr. Yuan Qian, Dr. Zhou Hongfeng and Dr. Zhou Pengfei—aimed at strengthening liquidity and...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666536860","title":"Wuhan YZY Biopharma Co - to Issue 35.6 Mln Domestic Shares at Rmb2.43 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2666536860","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666536860?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:36","pubTimestamp":1788961014,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nFWN4510FV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02496","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116111720","title":"YZYBIO-B Maintains Stable Share Base in August; 0.50 Million Options Lapse Under 2024 Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1116111720","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116111720?lang=en_us&edition=fundamental","pubTime":"2026-09-03 16:40","pubTimestamp":1788424841,"startTime":"0","endTime":"0","summary":"Wuhan YZY Biopharma Co., Ltd. (YZYBIO-B) reported no changes to its registered or issued share capital for the month ended 31 August 2026, according to its latest Monthly Return filed with Hong Kong...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148668631","title":"YZYBIO-B Trading Halt Announced Pending Insider Information Disclosure","url":"https://stock-news.laohu8.com/highlight/detail?id=1148668631","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148668631?lang=en_us&edition=fundamental","pubTime":"2026-08-31 09:13","pubTimestamp":1788138811,"startTime":"0","endTime":"0","summary":"YZYBIO-B (02496) has announced that trading in its shares has been suspended on the Stock Exchange of Hong Kong Limited since 9:00 a.m. on August 31, 2026.The suspension was implemented to facilitate...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663023379","title":"Trading in Wuhan YZY Biopharma H Shares Halted at 9:00 A.m. on Aug 31, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2663023379","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663023379?lang=en_us&edition=fundamental","pubTime":"2026-08-31 08:40","pubTimestamp":1788136826,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R039:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106082256","title":"YZYBIO-B Reports Narrowed Interim Loss of RMB 6.26 Million, Down 89.36% Year-on-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1106082256","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106082256?lang=en_us&edition=fundamental","pubTime":"2026-08-28 17:18","pubTimestamp":1787908719,"startTime":"0","endTime":"0","summary":"YZYBIO-B (02496) has announced its interim results for the six months ended June 30, 2026, revealing a significant reduction in its net loss. The company recorded a net loss of RMB 6.26 million for...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184412604","title":"YZYBIO-B Narrows H1 Loss on Lower R&D Spend; M701 NDA Accepted, Pipeline Advances","url":"https://stock-news.laohu8.com/highlight/detail?id=1184412604","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184412604?lang=en_us&edition=fundamental","pubTime":"2026-08-28 17:04","pubTimestamp":1787907876,"startTime":"0","endTime":"0","summary":"Wuhan-based biotech firm YZYBIO-B (YZY Biopharma) published its unaudited interim results for the six months ended 30 June 2026, highlighting a markedly reduced net loss and continued progress across...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"YZYBIO-B Narrows H1 Loss on Lower R&D Spend; M701 NDA Accepted, Pipeline Advances","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662068347","title":"Wuhan YZY Biopharma H1 FY26 Net Loss Narrows to RMB 6.26 Million; Revenue Falls 10.87% to RMB 33.14 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662068347","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662068347?lang=en_us&edition=fundamental","pubTime":"2026-08-28 16:46","pubTimestamp":1787906803,"startTime":"0","endTime":"0","summary":"Wuhan YZY Biopharma H1 FY26 net loss narrows to RMB 6.26 million; revenue falls 10.87% to RMB 33.14 millionWuhan Yzy Biopharma posted revenue of RMB 33.14 million; loss narrowed to RMB 6.26 million, E","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL9Dy1VZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145408618","title":"YZYBIO-B schedules 28 Aug 2026 board session to approve 1H 2026 interim results","url":"https://stock-news.laohu8.com/highlight/detail?id=1145408618","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145408618?lang=en_us&edition=fundamental","pubTime":"2026-08-18 16:48","pubTimestamp":1787042932,"startTime":"0","endTime":"0","summary":"Wuhan YZY Biopharma Co., Ltd. (YZYBIO-B, HKEX: 02496) has fixed 28 August 2026 for a board meeting aimed at reviewing and approving the company’s interim financial statements for the six months ended...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660682094","title":"Wuhan YZY Biopharma Schedules Board Meeting to Review Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660682094","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660682094?lang=en_us&edition=fundamental","pubTime":"2026-08-18 16:41","pubTimestamp":1787042484,"startTime":"0","endTime":"0","summary":"Wuhan YZY Biopharma schedules board meeting to review interim resultsWuhan YZY Biopharma scheduled a board meeting for Aug. 28, 2026 to review interim results for the six months ended June 30, 2026.Di","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL4WkK0p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132887864","title":"YZY Biopharma Reports No Change in Share Capital for July 2026; 1.25 Million Options Outstanding","url":"https://stock-news.laohu8.com/highlight/detail?id=1132887864","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132887864?lang=en_us&edition=fundamental","pubTime":"2026-08-05 16:48","pubTimestamp":1785919721,"startTime":"0","endTime":"0","summary":"Wuhan YZY Biopharma Co., Ltd. (YZY Biopharma) filed its Monthly Return for the period ended 31 July 2026, confirming that the company’s share structure remained stable during the month. Authorised...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162506633","title":"YZYBIO-B (02496) to Present Clinical Data for M701 at 2026 ASCO Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=1162506633","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162506633?lang=en_us&edition=fundamental","pubTime":"2026-05-22 20:08","pubTimestamp":1779451716,"startTime":"0","endTime":"0","summary":"YZYBIO-B (02496) has announced that clinical results from two studies of its core national Class 1 innovative drug M701, a \"CD3/EpCAM bispecific antibody,\" will be presented at the 2026 American...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637319080","title":"Wuhan YZY Biopharma says Phase III M701 trial prolongs puncture-free survival in malignant ascites","url":"https://stock-news.laohu8.com/highlight/detail?id=2637319080","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637319080?lang=en_us&edition=fundamental","pubTime":"2026-05-22 19:59","pubTimestamp":1779451164,"startTime":"0","endTime":"0","summary":"Wuhan Yzy Biopharma disclosed that results from two studies of its M701 CD3/EpCAM bispecific antibody will be presented at the 2026 ASCO Annual Meeting.A Phase III registrational study in malignant ascites showed M701 improved fluid control versus standard drainage, extended the time patients went without repeat procedures, and supported better reported quality of life.Overall survival was broadly similar between groups, while tolerability was described as comparable to the control arm.A randomized Phase II study in malignant pleural effusion linked to NSCLC showed stronger and more durable effusion control than drainage with or without local chemotherapy, with low rates of severe treatment-related side effects.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, inves","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nNDL5msJ4M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154204119","title":"YZYBIO-B Announces Supervisor Transition: Dr. Shi Jian Steps Down, Ms. Fang Lijuan Elected as Employee Representative","url":"https://stock-news.laohu8.com/highlight/detail?id=1154204119","media":"Bulletin Express","labels":["SGX","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154204119?lang=en_us&edition=fundamental","pubTime":"2026-05-15 16:43","pubTimestamp":1778834611,"startTime":"0","endTime":"0","summary":"Wuhan YZY Biopharma Co., Ltd. (YZYBIO-B) reported a change in its supervisory structure effective 15 May 2026. Employee representative supervisor Dr. Shi Jian has resigned for personal...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146997421","title":"YZYBIO-B (02496) Announces Election of Fang Lijuan as Second-Term Employee Representative Supervisor","url":"https://stock-news.laohu8.com/highlight/detail?id=1146997421","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146997421?lang=en_us&edition=fundamental","pubTime":"2026-05-15 16:37","pubTimestamp":1778834251,"startTime":"0","endTime":"0","summary":"YZYBIO-B (02496) has announced that Dr. Shi Jian has resigned from his position as employee representative supervisor due to personal career development reasons, effective May 15, 2026. Ms. Fang...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635670460","title":"Wuhan Yzy Biopharma names Fang Lijuan employee representative supervisor, replacing Shi Jian","url":"https://stock-news.laohu8.com/highlight/detail?id=2635670460","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635670460?lang=en_us&edition=fundamental","pubTime":"2026-05-15 16:33","pubTimestamp":1778834007,"startTime":"0","endTime":"0","summary":"Wuhan Yzy Biopharma named Fang Lijuan as employee representative supervisor, effective May 15, 2026.Fang is deputy director of Antibody Platform Department; she has 15 years of R&D experience in therapeutic antibodies, fusion proteins.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wuhan Yzy Biopharma Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on May 15, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL9YhpZB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158778344","title":"Wuhan YZY Biopharma’s NDA for Bispecific Antibody M701 Wins NMPA Acceptance","url":"https://stock-news.laohu8.com/highlight/detail?id=1158778344","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158778344?lang=en_us&edition=fundamental","pubTime":"2026-05-07 17:43","pubTimestamp":1778146988,"startTime":"0","endTime":"0","summary":"Wuhan YZY Biopharma Co., Ltd. announced that China’s National Medical Products Administration (NMPA) has formally accepted the New Drug Application for M701, a self-developed bispecific antibody...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181865718","title":"YZYBIO-B Receives NMPA Acceptance for M701 New Drug Application Targeting Malignant Ascites","url":"https://stock-news.laohu8.com/highlight/detail?id=1181865718","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181865718?lang=en_us&edition=fundamental","pubTime":"2026-05-07 17:38","pubTimestamp":1778146700,"startTime":"0","endTime":"0","summary":"YZYBIO-B (02496) has announced that the New Drug Application for its self-developed bispecific antibody drug M701, intended for the treatment of malignant ascites caused by advanced epithelial...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","BK1161","02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633511173","title":"BRIEF-Wuhan Yzy Biopharma Co Says NDA For M701 Accepted By NMPA For Treatment Of Malignant Ascites","url":"https://stock-news.laohu8.com/highlight/detail?id=2633511173","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633511173?lang=en_us&edition=fundamental","pubTime":"2026-05-07 17:34","pubTimestamp":1778146466,"startTime":"0","endTime":"0","summary":"BRIEF-Wuhan Yzy Biopharma Co Says NDA For M701 Accepted By NMPA For Treatment Of Malignant AscitesMay 7 (Reuters) - Wuhan YZY Biopharma Co Ltd 2496.HK:NDA FOR M701 ACCEPTED BY NMPA FOR TREATMENT OF MALIGNANT ASCITESFurther company coverage: 2496.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nFWN41K0CJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633111739","title":"Wuhan YZY Biopharma says China regulator accepts M701 NDA for malignant ascites","url":"https://stock-news.laohu8.com/highlight/detail?id=2633111739","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633111739?lang=en_us&edition=fundamental","pubTime":"2026-05-07 17:34","pubTimestamp":1778146442,"startTime":"0","endTime":"0","summary":"Wuhan YZY Biopharma NDA for M701 accepted by China NMPA for treatment of malignant ascites caused by advanced epithelial tumors.Filing supported by Phase III China trial data; company plans to present results at 2026 ASCO annual meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wuhan Yzy Biopharma Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on May 07, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDL9BMkxL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02496"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":37,"code":"91000000","status":"200"}]}}